[1]巨 星,巨新民,张宏利,等.复方万年青胶囊治疗晚期胆囊癌mFOLFOX6方案化疗所致不良反应临床研究*[J].陕西中医,2019,(8):1010-1013.
　JU Xing,JU Xinmin,ZHANG Hongli,et al.The effects of compound Wannianqing capsule on adverse reaction of advanced gallbladder carcinoma treated by mFOLFOX6 method chemotherapy[J].,2019,(8):1010-1013.
点击复制

复方万年青胶囊治疗晚期胆囊癌mFOLFOX6方案化疗所致不良反应临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年8期
页码:
1010-1013
栏目:
临床研究
出版日期:
2019-08-05

文章信息/Info

Title:
The effects of compound Wannianqing capsule on adverse reaction of advanced gallbladder carcinoma treated by mFOLFOX6 method chemotherapy
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.08.007
作者:
巨 星1; 巨新民2; 张宏利1; 严亢亢1; 张 雅1
1.西安市中心医院(西安 710004)；2.陕西省咸阳市永寿县人民医院普外科 (咸阳 713400)
Author(s):
JU Xing; JU Xinmin; ZHANG Hongli; et al.
Dispensary for Inpatients,Xi’an Central Hospital(Xi’an 710004)
关键词:
复方万年青胶囊; 化疗; 不良反应; 晚期胆囊癌; mFOLFOX6方案; 生活质量
Keywords:
Key words Compound Wannianqing capsule; Chemotherapy; Adverse reaction; Advanced gallbladder carcinoma; mFOLFOX6 method; Quality of life
分类号:
R735.8
文献标志码:
A
摘要:
摘 要 目的：观察复方万年青胶囊对晚期胆囊癌患者mFOLFOX6方案化疗所致不良反应的影响。方法：将186例初治晚期胆囊癌患者纳入本研究，采用随机数字表法将其分为观察组及对照组，每组93例。所有患者均给予mFOLFOX6方案化疗，观察组同时给予复方万年青胶囊口服，对照组则给予安慰剂口服。治疗期间，对两组患者的各类毒副反应进行观察。治疗前后，检测两组患者外周血T细胞亚群（CD3+及CD4+）及免疫球蛋白（IgG、IgA及IgM）含量。治疗前后，评价两组患者躯体健康、心理健康、物质生活及社会功能等生活质量评分。结果:治疗期间，观察组食欲下降、恶心呕吐、腹泻、白细胞降低、血红蛋白降低、血小板抑制、口腔黏膜损伤及肝功能异常等不良反应的发生率分别为25.8%、23.6%、19.1%、14.6%、21.3%、22.5%、7.8%及11.2%，均明显低于对照组（P＜0.05）。治疗后，观察组外周血中CD3+、CD4+、IgG、IgA及IgM含量均明显高于对照组，且躯体健康、心理健康、物质生活及社会功能评分亦明显高于对照组（P＜0.05）。结论:复方万年青胶囊可有效改善晚期胆囊癌患者mFOLFOX6方案化疗所致不良反应，提高患者生活质量及免疫功能。
Abstract:
Abstract Objective：To observe the effects of compound Wannianqing capsule on adverse reaction of advanced gallbladder carcinoma treated by mFOLFOX6 (oxaliplatin + calcium folinate + 5-fluorouracil) method chemotherapy. Methods：186 cases of advanced gallbladder carcinoma patients were randomly divided observation group (93 cases) and control group (93 cases). All patients were treated by mFOLFOX6 method,while compound Wannianqing capsule was treated in the observation group and placebo was given in control group. During the treatment,the adverse reactions were observed in the two groups. Before and after the treatment,the levels of CD3+,CD4+,IgG,IgA and IgM were detected in the two groups,while the life quality scores were observed,including mental health,physical health,social function and material life. Results:During the treatment,the rates of appetite loss,nausea,diarrhea,leukopenia,hemoglobin reduce,platelet inhibition,oral mucosal injury and abnormal liver function were 25.8%,23.6%,19.1%,14.6%,21.3%,22.5%,7.8% and 11.2% in observation group were significantly higher than control group（P＜0.05）. After the treatment,the levels of CD3+,CD4+,IgG,IgA and IgM in the observation group were significantly higher than control group (P＜0.05),while the scores of mental health,physical health,social function and material life were also significantly higher in the observation group than control group (P＜0.05). Conclusion：Compound Wannianqing capsule can improve the adverse reactions of advanced gallbladder carcinoma treated by mFOLFOX6 method chemotherapy,and promote the immune function and life quality in patients.

参考文献/References:

[1] Xie F,Xu X,Xu A,et al. Aberrant activation of Sonic hedgehog signaling in chronic cholecystitis and gallbladder carcinoma [J]. Hum Pathol,2014,45(3):513-521.
[2] 徐建庆,陈 晨,宋虎伟,等. 胆囊癌发病相关危险因素分析 [J]. 中国普通外科杂志,2015,24(2)：190-194.
[3] Kakaei F,Beheshtirouy S,Nejatollahi SM,et al. Surgical treatment of gallbladder carcinoma：a critical review [J]. Updates Surg,2015,67(4):339-351.
[4] 张 恒,白玉贤,张文杰,等. 进展期胆囊癌的治疗进展 [J]. 现代肿瘤医学,2015,23(19)：2865-2868.
[5] 童建东,袁 昕,汪 竹,等. 晚期原发性胆囊癌的化疗 [J]. 临床肿瘤学杂志,2006,11(7)：530-532.
[6] 何 浪,王 丹. 抗人胆囊癌杂交瘤细胞系的建立及其特性鉴定 [J]. 免疫学杂志,2010,26 (10)：894-896.
[7] 刘立业,仝林虎. 胆囊癌治疗的研究进展 [J]. 中国普通外科杂志,2018,27 (8):1048-1053.
[8] Shimizu T,Saijo N. Common toxicity criteria：version 2.0,an improved reference for grading the adverse reaction of cancer treatment [J]. Nihon Rinsho Japanese Journal of Clinical Medicine,2003,61(6)：937-942.
[9] Onuki K,Sugiyama H,Ishige K,et al. Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder [J]. J Gastroenterol,2014,49(4):702-714.
[10] Emmett CD,Barrett P,Gilliam AD,et al. Routine versus selective histological examination after cholecystectomy to exclude incidentalgallbladder carcinoma [J]. Ann R Coll Surg Engl,2015,97(7):526-529.
[11] Shirobe T,Maruyama S. Laparoscopic radical cholecystectomy with lymph node dissection for gallbladder carcinoma [J]. Surg Endosc,2015,29(8):2244-2250.
[12] 韩 扬,徐安安,符雪莲,等. 隐匿性胆囊癌的病理学分析 [J]. 同济大学学报：医学版,2017,38(2)：45-50.
[13] 张 毅,方永军,周 锋,等. 丹参酮ⅡＡ对脑出血大鼠灶周Nestin、Neun表达的影响 [J]. 陕西中医,2015,36(11)：1555-1558.
[14] 赵晓萍. 复方万年青胶囊的临床特点 [J]. 中国执业药师,2005,3(2)：26-27.
[15] 罗林明,石雅宁,姜懿纳,等. 人参抗肿瘤作用的有效成分及其机制研究进展 [J]. 中草药,2017,48(3)：582-596.
[16] 张智勇,郑 伟,常虎林,等. miR-182在胆囊癌中的表达及其对胆囊癌细胞增殖、侵袭能力的影响 [J]. 陕西医学杂志,2017,46(6)：689-698.
[17] 逯 双,杨培民,曹广尚. 白花蛇舌草活性成分多糖与黄酮研究进展 [J]. 中国中医药信息杂志,2016,23(3)：122-125.

相似文献/References:

[1]王树庚.健脾益气汤联合化疗治疗甲状腺癌及对患者免疫功能的影响[J].陕西中医,2016,(10):1372.
[2]万晓燕.芪术茯苓汤治疗恶性肿瘤化疗后白细胞减少临床研究[J].陕西中医,2019,(1):100.
　WAN Xiaoyan..Clinical study of Qizhu Fuling decoction in the treatment of malignant tumor after chemotherapy of white blood cell reduction[J].,2019,(8):100.
[3]高聪聪,范 筱,李 宁.益气健脾化积方对胃癌化疗疗效、患者安全性及预后影响的研究*[J].陕西中医,2019,(4):475.
[4]任宝中,李 媛△.益气化瘀方配合化疗治疗晚期非小细胞肺癌临床研究*[J].陕西中医,2019,(8):1036.
　REN Baozhong,LI Yuan..Application effect of TP chemotherapy Plus Yiqi Huayu decoction in advanced Non-small cell lung cancer patients[J].,2019,(8):1036.
[5]吴昭利,李成军,李仁廷,等.通麻汤联合穴位注射治疗结直肠癌奥沙利铂化疗相关外周神经毒性疗效研究*[J].陕西中医,2019,(9):1247.
　WU Zhaoli,LI Chengjun,LI Renting,et al.Clinical study on Tongma decoction combined with acupoint injection in the treatment of peripheral neurotoxicity related to oxaliplatin chemotherapy for colorectal cancer[J].,2019,(8):1247.
[6]童玫瑰,程 千.清肠解毒方对大肠癌术后复发化疗患者〖JZ〗肿瘤标记物水平及生活质量的影响*[J].陕西中医,2020,(1):53.
　TONG Meigui,CHENG Qian..Analysis of Qingchang Jiedu decoction on quality of life and tumor markers of 〖JZ〗patients with recurrent colorectal cancer after postoperative chemotherapy[J].,2020,(8):53.
[7]任东峰,孙国芳△.六君祛痰解毒汤联合化疗治疗非小细胞肺癌疗效〖JZ〗及对患者血管内皮生长因子的影响[J].陕西中医,2020,(1):63.

备注/Memo

备注/Memo:
*陕西省科技统筹创新工程计划项目（2013KTCQ03-08）
更新日期/Last Update: 2019-08-15